No abstract available
MeSH terms
-
Antibodies / analysis
-
Anticoagulants / adverse effects*
-
Antithrombins / therapeutic use
-
Arginine / analogs & derivatives
-
Benzimidazoles / therapeutic use
-
Chondroitin Sulfates / therapeutic use
-
Dabigatran
-
Dermatan Sulfate / therapeutic use
-
Fibrinolytic Agents / therapeutic use
-
Fondaparinux
-
Heparin / adverse effects*
-
Heparin / immunology
-
Heparitin Sulfate / therapeutic use
-
Hirudins
-
Peptide Fragments / therapeutic use
-
Pipecolic Acids / therapeutic use
-
Platelet Aggregation Inhibitors / therapeutic use
-
Polysaccharides / therapeutic use
-
Pyridines / therapeutic use
-
Recombinant Proteins / therapeutic use
-
Sulfonamides
-
Thrombin / antagonists & inhibitors
-
Thrombocytopenia / chemically induced*
-
Thrombocytopenia / therapy*
Substances
-
Antibodies
-
Anticoagulants
-
Antithrombins
-
Benzimidazoles
-
Fibrinolytic Agents
-
Hirudins
-
Peptide Fragments
-
Pipecolic Acids
-
Platelet Aggregation Inhibitors
-
Polysaccharides
-
Pyridines
-
Recombinant Proteins
-
Sulfonamides
-
Dermatan Sulfate
-
Heparin
-
Chondroitin Sulfates
-
Heparitin Sulfate
-
Arginine
-
danaparoid
-
Thrombin
-
Dabigatran
-
argatroban
-
Fondaparinux
-
bivalirudin